Logo image of RCKT

ROCKET PHARMACEUTICALS INC (RCKT) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RCKT - US77313F1066 - Common Stock

3.32 USD
-0.1 (-2.92%)
Last: 12/5/2025, 8:00:01 PM
3.35 USD
+0.03 (+0.9%)
After Hours: 12/5/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
RCKT revenue by date.RCKT revenue by date.
N/AN/AN/A
-62.09%
N/A
1,164.20%
N/A
77.32%
N/A
81.10%
N/A
78.55%
N/A
58.15%
EBITDA
YoY % growth
RCKT ebitda by date.RCKT ebitda by date.
-7.7M-20.35M
-164.29%
-7.5M
63.14%
-19.57M
-160.93%
-70.83M
-261.93%
-75.72M
-6.90%
-133.15M
-75.85%
-161.88M
-21.58%
-214.87M
-32.73%
-249.361M
-16.05%
-263.83M
-5.80%
N/A
14.87%
N/A
9.74%
N/A
9.09%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
RCKT ebit by date.RCKT ebit by date.
-7.7M-20.4M
-164.94%
-7.57M
62.89%
-19.77M
-161.16%
-71.16M
-259.94%
-76.15M
-7.01%
-134.3M
-76.36%
-167.25M
-24.53%
-221.14M
-32.22%
-256.459M
-15.97%
-273.205M
-6.53%
N/A
10.26%
N/A
11.94%
N/A
-1.72%
N/A
15.91%
N/A
24.38%
N/A
64.12%
N/A
440.56%
N/A
160.45%
Operating Margin
RCKT operating margin by date.RCKT operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
RCKT eps by date.RCKT eps by date.
N/A-3.56
8.39%
-6.40
-79.78%
N/A-1.88-1.58
15.96%
-2.51
-58.86%
-2.68
-6.77%
-3.29
-22.76%
-2.94
10.64%
-2.73
7.14%
N/A
22.11%
N/A
24.93%
N/A
17.15%
N/A
19.02%
N/A
32.38%
N/A
70.14%
N/A
499.39%
N/A
129.92%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.45
27.48%
-0.46
18.56%
-0.42
29.12%
-0.41
8.48%
-0.38
15.61%
Revenue
Q2Q % growth
316.2K1.827M4.878M
EBITDA
Q2Q % growth
-40.238M
24.53%
-43.889M
28.52%
-45.882M
26.13%
-49.813M
-14.22%
N/A
EBIT
Q2Q % growth
-52.036M
17.00%
-50.297M
21.88%
-51.836M
23.41%
-54.13M
-3.26%
-48.707M
6.40%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.45
36.62%
-0.520.0712.64%
Q2 2025
Q2Q % growth
-0.59
20.27%
-0.57-0.02-3.91%
Q1 2025
Q2Q % growth
-0.56
15.15%
-0.630.0710.56%
Q4 2024
Q2Q % growth
-0.62
3.13%
-0.730.1115.34%
Q3 2024
Q2Q % growth
-0.71
5.33%
-0.780.078.41%
Q2 2024
Q2Q % growth
-0.74
9.76%
-0.73-0.01-1.16%
Q1 2024
Q2Q % growth
-0.66
9.59%
-0.690.034.96%
Q4 2023
Q2Q % growth
-0.64
30.43%
-0.800.1620.15%
Q3 2023
Q2Q % growth
-0.75
13.79%
-0.820.079.05%
Q2 2023
Q2Q % growth
-0.82
1.20%
-0.81-0.01-1.76%
Q1 2023
Q2Q % growth
-0.73
-8.96%
-0.870.1415.97%
Q4 2022
Q2Q % growth
-0.92
-33.33%
-0.82-0.10-12.34%
Q3 2022
Q2Q % growth
-0.87
-10.13%
-0.81-0.06-8.07%
Q2 2022
Q2Q % growth
-0.83
-50.91%
-0.70-0.13-19.23%
Q1 2022
Q2Q % growth
-0.67
-3.08%
-0.720.057.48%
Q4 2021
Q2Q % growth
-0.69
36.11%
-0.780.0911.41%
Q3 2021
Q2Q % growth
-0.79
-49.06%
-0.62-0.17-27.73%
Q2 2021
Q2Q % growth
-0.55
-22.22%
-0.660.1116.93%
Q1 2021
Q2Q % growth
-0.65
-44.44%
-0.700.057.28%
Q4 2020
Q2Q % growth
-1.08
-176.92%
-0.52-0.56-105.78%
Q3 2020
Q2Q % growth
-0.53
-39.47%
-0.47-0.06-11.85%
Q2 2020
Q2Q % growth
-0.45
-18.42%
-0.520.0712.74%
Q1 2020
Q2Q % growth
-0.45
-4.65%
-0.500.059.50%
Q4 2019
Q2Q % growth
-0.39 -0.500.1121.37%
Q3 2019
Q2Q % growth
-0.38 -0.500.1224.31%
Q2 2019
Q2Q % growth
-0.38 -0.500.1224.63%
Q1 2019
Q2Q % growth
-0.43 -0.640.2132.55%
RCKT Yearly EPS VS EstimatesRCKT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4 -6 -8 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
283.336K-283.336K-100.00%
Q2 2025
Q2Q % growth
4.451M-4.451M-100.00%
Q1 2025
Q2Q % growth
1.898M-1.898M-100.00%
Q4 2024
Q2Q % growth
31.926K-31.926K-100.00%
Q3 2024
Q2Q % growth
719.1K-719.1K-100.00%
Q4 2022
Q2Q % growth
102K-102K-100.00%
RCKT Yearly Revenue VS EstimatesRCKT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2024 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.38% -5.54% 1.67% 0.07%
Revenue-100% -100% -100% -100%